Contrast ultrasound dispersion imaging (CUDI) as a diagnostic modality in the diagnosis of renal cell carcinoma.

Contrast ultrasound dispersion imaging (CUDI) as a diagnostic modality in the diagnosis of renal cell carcinoma. - CUDI-RCC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49171

Enrollment

Registered

2020-07-12

Start date

2020-12-02

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney cancer renal cell carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: · age * 18 years · signed informed consent · scheduled for a radical- or partial nephrectomy for the suspicious of a renal tumor.

Exclusion criteria

Exclusion criteria: · Earlier treatment of renal masses · History of any clinically evidence of cardiac right-to-left shunts · Severe pulmonary hypertension (pulmonary artery pressure >90 mmHg) or uncontrolled systemic hypertension or respiratory distress syndrome · Has any medical condition or other circumstances which would significantly decrease the chances of obtaining reliable data, achieving study objectives, or completing the study · Is incapable of understanding the language in which the information for the patient is given · Tumor cannot be visualized/localized on ultrasound imaging

Design outcomes

Primary

Measure	Time frame
Parameters defined by CUDI-quantification that correlate with the pathology results.	—

Secondary

Measure	Time frame
Nvt	—

Countries

Netherlands

Outcome results